Navigation Links
Healthnostics' Medbioworld.com Portal Web Site to Include Social Networking Features
Date:10/7/2009

NEW YORK, Oct. 7 /PRNewswire-FirstCall/ - Healthnostics, Inc. (OTC PK: HNSS), a medical and biotechnology analytics company, announced today details regarding the social networking features of their MedBioWorld Web Portal under re-design. Using the Facebook(C) model that gives individuals greater power to share and connect, MedBioWorld will build an interactive layer that allows users to comment and establish a presence to share and access biomedical information.

MedBioWorld is expanding its rich biomedical content already available to its professional customer base to include a more general audience. Providing this new audience with the means to interact with professional level content should lead to an increased rate of user return and the viral spread of site awareness. The user experience will be further enhanced by providing biomedical-based widgets and other mini-applications that will attract larger audiences and deliver user profiles related to site usage for increased content targeting and topic specific development.

"Integrating the user in an active, participatory way is critical to user growth for the MedBioWorld site," said Alan Grofe, president. "A social networking approach to user involvement will help us focus our newly expanded user base on biomedical information that is not only trusted and relevant, but is also entertaining."

About Healthnostics

Healthnostics, Inc. is a medical and biotechnology analytics company that provides comprehensive patient clinical monitoring and risk management systems to acute care hospitals and utilizes its Internet portals to deliver medical and biotechnology resource information to industry professionals as well as to the general public. Healthnostics' major products include: MedGuardian, a patient care monitoring and risk management system for hospitals that is fully Web-based; and through the MedBioWeb subsidiary, MedBioWorld(TM), one of the largest professional medical and biotechnology directory resource and reference portal sites on the Internet, and FamilyMedicalNet, a companion consumer healthcare information portal.

For further information please visit Healthnostics www.healthnostics.com, MedBioWorld www.medbioworld.com, and FamilyMedicalNet www.familymedicalnet.com.

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.

CONTACT: Alan Grofe, P. (703) 754-7126

SOURCE Healthnostics, Inc.


'/>"/>
SOURCE Healthnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Healthnostics Unveils Biomedical Content Strategy for Medbioworld.com
2. Web Portal Makes Organ Donation Easy
3. CSC and HealthTrio Team to Offer Portal and Personal Health Record Solution
4. BioSpace Launches Life Science Career Content and Resources from the Biotech Work Portal
5. Sigma-Aldrich Streamlines Access to Advanced Stem Cell Research Portfolio and Opens Stem Cell Biology Community Through New Web Portal
6. Cyprotex Launches Cloe(R) Gateway, its Secure web Portal for Access to Cyprotex Services Including an Enhanced Version of Cloe(R) PK.
7. University of Michigan Installs Neuro Kinetics I-Portal(R) NOTC System
8. First-Ever Egg Donor Web Portal Becomes One of The Largest Resources for Aspiring Parents in the U.S.
9. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
10. HealthTrust Expands Contract With Instrumentation Laboratory for Critical Care Portfolio to Include Consorta
11. MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is pleased ... received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of ... Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform ...
(Date:6/23/2016)... ... 23, 2016 , ... Supplyframe, the Industry Network for electronics ... Lab . Located in Pasadena, Calif., the Design Lab’s mission is to bring ... designed, built and brought to market. , The Design Lab is Supplyframe’s physical ...
(Date:6/23/2016)... Calif. , June 23, 2016  Blueprint Bio, ... biological discoveries to the medical community, has closed its ... Matthew Nunez . "We have received ... with the capital we need to meet our current ... essentially provide us the runway to complete validation on ...
Breaking Biology Technology:
(Date:6/9/2016)... leader in attendance control systems is proud to announce the introduction of fingerprint attendance ... the right employees are actually signing in, and to even control the opening of ... ... ... Photo - ...
(Date:6/3/2016)... , June 3, 2016 ... Management) von Nepal ... und Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, ... führend in der Produktion und Implementierung von ... der Ausschreibung im Januar teilgenommen, aber Decatur ...
(Date:6/2/2016)... LONDON , June 2, 2016 ... Systems, Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & ... intelligence provider visiongain offers comprehensive analysis of ... that this market will generate revenues of $17.98 billion ... Systems acquired DVTEL Inc, a leader in software and ...
Breaking Biology News(10 mins):